Welcome to the Investor Relations page. If you are a member of the investment community with a question about Regeneron, please call our Investor Relations Line at (914) 345-7400.
For an e-mail response to your Regeneron investment question, please contact us at invest@regeneron.com.
Regeneron is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of cancer, eye diseases, and inflammatory diseases and has candidates in preclinical programs for other diseases and disorders.
More about Regeneron Pharmaceuticals >>
 |
 | Webcast Regeneron Pharmaceuticals at Needham & Company Biotechnology & Medical Technology Conference (Replay) Jun 11, 2009 at 2:30 p.m. ET |
| ||||||||||
|
| Upcoming Events |
| | Regeneron Annual Meeting of Shareholders | | Date: 6/12/2009 Time: 10:30 a.m. EST | Westchester Marriott Hotel, 670 White Plains Road, Tarrytown, NY 10591  Meeting Information and Directions | |
|
| Recent Press Releases |
| Sanofi-aventis and Regeneron Announce Results from Phase 2 Study with Aflibercept (VEGF Trap) in Advanced Ovarian Cancer Patients with Recurrent Symptomatic Malignant Ascites - 06/11/09 |
| PARIS & TARRYTOWN, N.Y.--(BUSINESS WIRE)--Jun. 11, 2009-- Sanofi-aventis (Euronext: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that advanced ovarian cancer patients with recurrent sy... Full Article >> |
|
| Regeneron Converts Interleukin-1 Antibody Opt-In Rights to Royalty Agreement - 06/11/09 |
| TARRYTOWN, N.Y.--(BUSINESS WIRE)--Jun. 11, 2009-- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced today that it has entered into two royalty agreements with Novartis Pharma AG that replace a previous collaboration an... Full Article >> |
|
| Regeneron Announces Presentation at the 8th Annual Needham Life Sciences Conference - 06/08/09 |
| TARRYTOWN, N.Y.--(BUSINESS WIRE)--Jun. 8, 2009-- Regeneron Pharmaceuticals, Inc. (Nasdaq:REGN) will webcast its presentation at the 8th Annual Needham Life Sciences Conference on Thursday, June 11, 2009. The presentation, whi... Full Article >> |
|
|
|
|
|
| © 2007, The Nasdaq Stock Market, Inc. |
 Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. |
Stock Quote
|
|
|
Featured Report
| |||||||||||
|
|
|
|